Senior Medical Strategy Lead, Hematology-Oncology

IQVIA; Barcelona; Sur place; EUR 150 000 - 190 000; Plein temps

Résumé du poste

IQVIA, a leading global provider of clinical research services and healthcare insights, seeks a Medical Director for the Hematology-Oncology Center of Excellence. You will shape medical strategy, provide expert input across clinical development plans, and engage with clients and internal teams to advance oncology initiatives.

The role emphasizes leadership in proposal development, scientific leadership throughout R&D lifecycles, and collaboration with commercial and operational groups to drive

Qualifications

• MD with oncology training; hematology experience is a plus.
• Typically 5–7 years of relevant experience.
• Experience leading R&D processes and cross-functional projects.

Responsabilités

• Provide strategic medical and scientific SME input to IQVIA in hematology-oncology.
• Support proposals, RFP responses, and bid-defense meetings.
• Maintain awareness of latest literature in hematology and oncology.
• Prepare for and participate in client meetings and governance sessions.
• Coach project teams to align execution with medical understanding.
• Collaborate with Business Development, Operations, and others.

Connaissances

Excellent communication & presentation

Interpersonal skills

Strategic thinking

Financial acumen

Negotiation & influencing

Cross-functional collaboration

Scientific/analytical mindset

Formation

MD / Doctor of Medicine with oncology training

Hematology training or solid tumor experience

Description du poste

IQVIA, a leading global provider of clinical research services and healthcare insights, seeks a Medical Director for the Hematology-Oncology Center of Excellence. You will shape medical strategy, provide expert input across clinical development plans, and engage with clients and internal teams to advance oncology initiatives.

The role emphasizes leadership in proposal development, scientific leadership throughout R&D lifecycles, and collaboration with commercial and operational groups to drive